Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125844423 | 12584442 | 3 | F | 20160802 | 20160722 | 20160817 | EXP | JP-SA-2016SA129665 | AVENTIS | 0.00 | E | M | Y | 0.00000 | 20160817 | OT | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125844423 | 12584442 | 1 | PS | TAXOTERE | DOCETAXEL | 1 | Unknown | U | UNKNOWN | 20449 | 75 | MG/M**2 | /cycle | ||||||
| 125844423 | 12584442 | 2 | SS | CISPLATIN. | CISPLATIN | 1 | Unknown | U | UNKNOWN | 0 | 75 | MG/M**2 | /cycle | ||||||
| 125844423 | 12584442 | 3 | SS | 5-FU | FLUOROURACIL | 1 | Unknown | U | UNKNOWN | 0 | 750 | MG/M**2 | /cycle |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125844423 | 12584442 | 1 | Oesophageal carcinoma |
| 125844423 | 12584442 | 2 | Oesophageal carcinoma |
| 125844423 | 12584442 | 3 | Oesophageal carcinoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125844423 | 12584442 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125844423 | 12584442 | Altered state of consciousness | |
| 125844423 | 12584442 | Hyperammonaemic encephalopathy | |
| 125844423 | 12584442 | Neutrophil count decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |